2026 NPPES data Hematology & Oncology Physician NPI 1629419494 MBBS
Verify on CMS →

Aman Opneja, MBBS

Hematology & Oncology Physician in Raleigh, North Carolina.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
333
Medicare Part D claims · 59 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
87.1/100
▲ 4 pts above national avg 83.1 · Above neutral
Industry payments
$10.7K
9 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Aman Opneja, MBBS reported a CMS MIPS final score of 87.1/100 - above the 83.1 national average - and filed 333 Medicare Part D claims in 2023.

87.1/100
MIPS score · +4 vs avg
333
Part D claims, 2023
91%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Aman Opneja, MBBS's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

87 Top 46% higher than 54% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90+: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Aman Opneja, MBBS sits

This provider among hematology & oncology physician peers

Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Aman Opneja, MBBS writes more Part D claims than 25% of them and scores higher on MIPS quality than 53% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.148.372.496.6Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 65Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 78Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 23Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 62Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 73Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 25Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 35Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 58Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 30Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 10Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 2Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 33Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 90Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 37Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 38Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 20Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 82Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 87Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 68Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 15Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 3Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 77Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 55Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 17Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 28Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 88Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 53Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 55Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 60Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 5Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 43Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 85Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 20Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 18Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 67Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 27Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 92Aman Opneja, MBBS-Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 53
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Aman Opneja, MBBS. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Aman Opneja, MBBS practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Aman Opneja, MBBS?

High performer (top quartile)

NPI registry status

Active

Issued 07/09/2013

NPI 1629419494

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

333 61% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

87.1/100 4 pts vs avg

Above neutral band

vs 83.1 national avg

Specialty distribution in North Carolina

How Hematology & Oncology Physician compares to other specialties among North Carolina providers

North Carolina providers
Clinical Social Worker - 7.1%Clinical Social Worker7.1%Behavior Technician - 6.4%Behavior Technician6.4%Pharmacist - 5%Pharmacist5%Student in an Organized Health Care Education/Training Program - 4.5%Student in an Organized Health Care Education/Training Program4.5%Physical Therapist - 4.3%Physical Therapist4.3%Physician Assistant - 4.2%Physician Assistant4.2%Hematology & Oncology Physician - 0.2%Hematology & Oncology Physician0.2%
Largest specialties in North Carolina (% of in-state providers)

Medicare quality performance, MIPS

Aman Opneja, MBBS's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
87.1/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) - 87.1/100 vs national avg 83.1

0%100%National avg83%87.1%
MIPS final score (Hematology & Oncology Physician) - 87.1/100 vs national avg 83.1
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Aman Opneja, MBBS appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MBBS credentials at 3404 WAKE FOREST RD STE 100, Raleigh, NC, 27609, with a listed phone of (919) 682-5970. NPI 1629419494 was issued on 07/09/2013.

Medicare Part D records for calendar year 2023 show 333 prescription claims written by this provider, covering 59 Medicare beneficiaries and totaling roughly $185K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 15.0%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 87.1/100 for the 2023 performance year (Quality 77.4, Cost 62.9), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3404 WAKE FOREST RD STE 100
Raleigh, NC 27609

Provider Details

NPI 1629419494
Specialty Hematology & Oncology Physician
Credentials MBBS
Gender Male
NPI Issued 07/09/2013

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

87.0923
Final Score
Avg: 83.1
77.4385
Quality
62.8691
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Aman Opneja, MBBS bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Duke Health Integrated Practice Inc
Durham, NC

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Aman Opneja, MBBS. Source: openpaymentsdata.cms.gov.

Total received

$10.7K

Largest payer

ARRAY BIOPHARMA INC

Most common payment type

Travel and Lodging

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

Aman Opneja, MBBS - brand share 9.0%
Hematology & Oncology Physician average

9% brand-name claims vs 91% generic, on 333 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

333
Total Claims
$185K
Total Drug Cost
59
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
364
Total Day Supply
7,593
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$179K
Generic Drug Cost
$6K
Opioid Claims
50 (15.0% rate)

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
1.92
Gender Split
56% female / 44% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Aman Opneja, MBBS prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ondansetron Hcl
43
Dexamethasone
40
Prochlorperazine Maleate
35
Oxycodone Hcl
23
Gabapentin
19
Potassium Chloride
12
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Aman Opneja, MBBS fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Aman Opneja, MBBS's 333 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in North Carolina

Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Opneja.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the North Carolina medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Aman Opneja, MBBS's specialty?
Aman Opneja, MBBS specializes in Hematology & Oncology Physician and practices in Raleigh, North Carolina. Credentials: MBBS.
How much does Aman Opneja, MBBS prescribe under Medicare Part D?
In 2023, Aman Opneja, MBBS wrote 333 Medicare Part D claims totaling $185K in drug costs for 59 beneficiaries.
What is Aman Opneja, MBBS's Medicare quality score?
Aman Opneja, MBBS has a CMS MIPS Final Score of 87.1/100 (Quality: 77.4, Cost: 62.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Aman Opneja, MBBS located?
Aman Opneja, MBBS is located at 3404 WAKE FOREST RD STE 100, Raleigh, NC, 27609. Phone: (919) 682-5970.
What is Aman Opneja, MBBS's NPI number?
Aman Opneja, MBBS's National Provider Identifier (NPI) is 1629419494, issued on 07/09/2013.
Does Aman Opneja, MBBS prescribe more brand-name or generic drugs?
Aman Opneja, MBBS's prescribing is 9% brand-name and 91% generic drugs by claim count, with $179K in brand drug costs.
Does Aman Opneja, MBBS prescribe opioids?
Yes, Aman Opneja, MBBS had 50 opioid claims in 2023 with an opioid prescribing rate of 15.0%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Aman Opneja, MBBS prescribe most often?
Based on 2023 Medicare Part D data, Aman Opneja, MBBS's most frequently prescribed drugs include Ondansetron Hcl, Dexamethasone, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Aman Opneja, MBBS accept Medicare?
Aman Opneja, MBBS appears in CMS Medicare data with 333 Part D claims and 59 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Aman Opneja, MBBS's credentials?
Aman Opneja, MBBS's NPI is 1629419494 with credentials MBBS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.